Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
Nothing big here, just the United States announcing plans to take over outer space....
Meta said it "respectfully" disagrees with the New Mexico jury's verdict and vowed to appeal the ruling ahead of the lawsuit's next phase....
L Todd Wood talks with financial pro Tom Teague on the theory that the war is all about controlling global shipping. Darin Gaub opines on the war, as well as Montana dark money infiltration....
